The pathogenesis of pulmonary inflammation and fibrosis in T2DM involves multiple mechanisms, including oxidative stress [17], chronic inflammation [16], epithelial–mesenchymal transition (EMT) [18], and activation of the transforming growth factor-β (TGF-β)/Smad signaling pathway [19]. Here, TGFB1 is linked to type 2 diabetes mellitus.